1. Home
  2. KEQU vs CTNM Comparison

KEQU vs CTNM Comparison

Compare KEQU & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KEQU
  • CTNM
  • Stock Information
  • Founded
  • KEQU 1906
  • CTNM 2009
  • Country
  • KEQU United States
  • CTNM United States
  • Employees
  • KEQU N/A
  • CTNM N/A
  • Industry
  • KEQU Medical Specialities
  • CTNM
  • Sector
  • KEQU Industrials
  • CTNM
  • Exchange
  • KEQU Nasdaq
  • CTNM Nasdaq
  • Market Cap
  • KEQU 106.0M
  • CTNM 114.1M
  • IPO Year
  • KEQU N/A
  • CTNM 2024
  • Fundamental
  • Price
  • KEQU $38.83
  • CTNM $4.43
  • Analyst Decision
  • KEQU
  • CTNM Strong Buy
  • Analyst Count
  • KEQU 0
  • CTNM 4
  • Target Price
  • KEQU N/A
  • CTNM $22.50
  • AVG Volume (30 Days)
  • KEQU 8.2K
  • CTNM 100.8K
  • Earning Date
  • KEQU 06-25-2025
  • CTNM 05-14-2025
  • Dividend Yield
  • KEQU N/A
  • CTNM N/A
  • EPS Growth
  • KEQU 102.06
  • CTNM N/A
  • EPS
  • KEQU 5.90
  • CTNM N/A
  • Revenue
  • KEQU $220,026,000.00
  • CTNM N/A
  • Revenue This Year
  • KEQU N/A
  • CTNM N/A
  • Revenue Next Year
  • KEQU N/A
  • CTNM N/A
  • P/E Ratio
  • KEQU $6.52
  • CTNM N/A
  • Revenue Growth
  • KEQU 9.44
  • CTNM N/A
  • 52 Week Low
  • KEQU $30.33
  • CTNM $3.35
  • 52 Week High
  • KEQU $71.33
  • CTNM $22.00
  • Technical
  • Relative Strength Index (RSI)
  • KEQU 58.95
  • CTNM N/A
  • Support Level
  • KEQU $35.53
  • CTNM N/A
  • Resistance Level
  • KEQU $40.49
  • CTNM N/A
  • Average True Range (ATR)
  • KEQU 1.69
  • CTNM 0.00
  • MACD
  • KEQU 0.47
  • CTNM 0.00
  • Stochastic Oscillator
  • KEQU 71.91
  • CTNM 0.00

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About CTNM Contineum Therapeutics Inc. Class A Common Stock

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

Share on Social Networks: